SpringWorks Therapeutics Inc
NASDAQ:SWTX
SpringWorks Therapeutics Inc
NASDAQ:SWTX
Price:
46.99
USD
0.02%
Market Closed
Market Cap:
$3.5B
Cash Flow Statement
Cash Flow Statement
SpringWorks Therapeutics Inc
SpringWorks Therapeutics Inc
Currency: USD
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||||||||
| Net Income |
(29)
|
(36)
|
(48)
|
(58)
|
(62)
|
(68)
|
(73)
|
(46)
|
(60)
|
(87)
|
(107)
|
(174)
|
(206)
|
(228)
|
(259)
|
(277)
|
(289)
|
(298)
|
(305)
|
(325)
|
(339)
|
(301)
|
(275)
|
(258)
|
(254)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
3
|
3
|
4
|
|
| Stock-Based Compensation |
2
|
2
|
3
|
3
|
4
|
6
|
8
|
10
|
16
|
22
|
30
|
38
|
48
|
58
|
66
|
73
|
79
|
84
|
88
|
95
|
102
|
105
|
108
|
109
|
109
|
|
| Other Non-Cash Items |
2
|
2
|
5
|
6
|
6
|
9
|
9
|
12
|
18
|
24
|
32
|
40
|
51
|
60
|
70
|
77
|
84
|
89
|
94
|
101
|
108
|
112
|
116
|
117
|
122
|
|
| Change in Working Capital |
6
|
5
|
9
|
5
|
(1)
|
(0)
|
1
|
1
|
5
|
8
|
7
|
5
|
(1)
|
6
|
35
|
38
|
29
|
24
|
(4)
|
(1)
|
(11)
|
(48)
|
(53)
|
(38)
|
(37)
|
|
| Cash from Operating Activities |
(21)
N/A
|
(30)
-40%
|
(34)
-15%
|
(47)
-38%
|
(57)
-19%
|
(60)
-5%
|
(63)
-6%
|
(32)
+49%
|
(37)
-15%
|
(54)
-47%
|
(66)
-23%
|
(128)
-92%
|
(155)
-22%
|
(161)
-4%
|
(154)
+5%
|
(162)
-5%
|
(175)
-8%
|
(183)
-5%
|
(214)
-17%
|
(223)
-4%
|
(240)
-8%
|
(234)
+3%
|
(209)
+11%
|
(176)
+16%
|
(165)
+6%
|
|
| Investing Cash Flow | ||||||||||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(2)
|
(4)
|
(7)
|
(10)
|
(10)
|
(11)
|
(11)
|
(11)
|
(7)
|
(5)
|
(14)
|
(12)
|
(21)
|
(20)
|
|
| Other Items |
0
|
(4)
|
(4)
|
(4)
|
0
|
(68)
|
(196)
|
(418)
|
(449)
|
(358)
|
(195)
|
86
|
145
|
152
|
206
|
(205)
|
(133)
|
(98)
|
(150)
|
42
|
(37)
|
(89)
|
(96)
|
85
|
137
|
|
| Cash from Investing Activities |
(1)
N/A
|
(4)
-676%
|
(4)
-4%
|
(4)
+4%
|
(4)
+2%
|
(69)
-1 551%
|
(196)
-186%
|
(419)
-113%
|
(450)
-7%
|
(359)
+20%
|
(195)
+46%
|
84
N/A
|
141
+69%
|
145
+3%
|
196
+35%
|
(216)
N/A
|
(143)
+33%
|
(109)
+24%
|
(161)
-47%
|
35
N/A
|
(42)
N/A
|
(103)
-143%
|
(109)
-6%
|
65
N/A
|
116
+80%
|
|
| Financing Cash Flow | ||||||||||||||||||||||||||
| Net Issuance of Common Stock |
214
|
164
|
334
|
334
|
170
|
170
|
1
|
270
|
271
|
271
|
271
|
1
|
1
|
1
|
341
|
341
|
339
|
338
|
(2)
|
297
|
298
|
302
|
303
|
5
|
(5)
|
|
| Cash from Financing Activities |
214
N/A
|
164
-24%
|
334
+104%
|
334
+0%
|
170
-49%
|
170
+0%
|
1
-100%
|
270
+50 936%
|
271
+0%
|
271
+0%
|
271
0%
|
1
-100%
|
1
-9%
|
1
-21%
|
341
+40 454%
|
341
+0%
|
339
-1%
|
338
0%
|
(2)
N/A
|
297
N/A
|
298
+0%
|
302
+1%
|
303
+1%
|
5
-98%
|
(5)
N/A
|
|
| Change in Cash | ||||||||||||||||||||||||||
| Net Change in Cash |
192
N/A
|
130
-33%
|
295
+127%
|
282
-4%
|
109
-61%
|
41
-62%
|
(259)
N/A
|
(181)
+30%
|
(216)
-19%
|
(142)
+34%
|
9
N/A
|
(43)
N/A
|
(13)
+69%
|
(15)
-11%
|
383
N/A
|
(36)
N/A
|
20
N/A
|
45
+122%
|
(377)
N/A
|
109
N/A
|
16
-86%
|
(35)
N/A
|
(14)
+59%
|
(106)
-637%
|
(54)
+49%
|
|
| Free Cash Flow | ||||||||||||||||||||||||||
| Free Cash Flow |
(22)
N/A
|
(31)
-40%
|
(35)
-15%
|
(48)
-36%
|
(57)
-19%
|
(60)
-5%
|
(64)
-6%
|
(33)
+49%
|
(37)
-14%
|
(55)
-46%
|
(67)
-23%
|
(130)
-94%
|
(160)
-23%
|
(168)
-5%
|
(164)
+2%
|
(172)
-5%
|
(185)
-8%
|
(195)
-5%
|
(226)
-16%
|
(230)
-2%
|
(245)
-6%
|
(248)
-1%
|
(221)
+11%
|
(196)
+11%
|
(186)
+5%
|
|
Switch to:
Switch to:
See Also
Discover More
